National Trend in Multivessel Percutaneous Coronary Intervention in Patients with Diabetes Mellitus in the United States

Document Type


Publication Date




Patients with diabetes and multivessel coronary artery disease treated with multivessel percutaneous coronary intervention (MVPCI) have higher mortality, non-fatal myocardial infarction and repeat revascularization rates compared to coronary artery bypass graft surgery (CABG). Our study objective is to assess the trend of MVPCI with stent placement in diabetic patients.


Data were obtained from nationwide inpatient sample from 2006-2012, which is a 20% stratified probability sample of discharges in all community hospitals participating in Healthcare Cost and Utilization Project. International Classification of Diseases 9 codes were used to identify diabetic patients who underwent percutaneous coronary intervention with stents in two or more vessels. Patients who had history of CABG, cardiac transplant, missing data, or were


A total of 41,586 patients underwent MVPCI between 2006 and 2012. The mean age of the patients undergoing MVPCI was 65.2±11.46 years. There were 59.89% males and 40.11% females. The trend analysis showed that incidence of MVPCI in diabetics decreased by 40.49% from a peak of 8179 in 2006 to 4867 in 2012 (Figure). Drug eluting stents were used in 78% patients, while non-drug eluting stents were used in 15.4% patients, and 6.6% of the patients received both.


There was a significant decrease in the number of MVPCI procedures performed on diabetic patients with multivessel coronary artery disease between year 2006 and 2012.


Poster presentation at TCT Conference 2015 (October 11-15, 2015) in San Francisco, CA.